DDrare: Database of Drug Development for Rare Diseases

Ketorolac (DrugBank: Ketorolac)

2 diseases

ID	Disease name (Link within this page)	Number of trials
70	Spinal stenosis	1
226	Interstitial cystitis with Hunners ulcer	1

70. Spinal stenosis [ 91 clinical trials, 195 drugs, (DrugBank: 54 drugs), 60 drug target genes, 85 drug target pathways]

Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 91 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02700451 (ClinicalTrials.gov)	March 2016	18/2/2016	Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes	A Randomized Controlled Trial of Post-operative Acetaminophen Versus Nonsteroidal Anti-Inflammatory Drug (NSAID) Use on Lumbar Spinal Fusion Outcomes	Lumbar Osteoarthritis;Spondylosis;Lumbar Disc Disease;Spinal Stenosis	Drug: Ketorolac;Drug: Acetaminophen;Drug: Placebo	Hospital for Special Surgery, New York	NULL	Active, not recruiting	18 Years	75 Years	All	300	N/A	United States

226. Interstitial cystitis with Hunners ulcer [ 133 clinical trials, 151 drugs, (DrugBank: 46 drugs), 48 drug target genes, 137 drug target pathways]

Searched query = "Interstitial cystitis with Hunners ulcer", "Interstitial cystitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 133 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02000401 (ClinicalTrials.gov)	May 2012	19/11/2013	Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain	To Evaluate the Efficacy, Tolerability, and Safety of Intranasal Ketorolac Tromethamine (Sprix) as an Option for Acute (up to 5 Days) Pain Management Adult Interstitial Cystitis Patients Experiencing a Flare of Pain	Interstitial Cystitis	Drug: Ketorolac Tromethamine	Citrus Valley Medical Research, Inc.	NULL	Completed	18 Years	64 Years	Female	15	Phase 4	United States